the Phenotypic and Genetic Profile of Patients With Early Onset Schizophrenia Associated With Autism Spectrum Disorder.
GenAuDiss
Exploration and Characterization of the Phenotypic and Genetic Profile of Patients With Early Onset Schizophrenia Associated With Autism Spectrum Disorder and Their First-degree Relatives (GenAuDiss).
1 other identifier
interventional
111
1 country
1
Brief Summary
Early onset schizophrenia "early dissociative disorder" is a rare disorder with a low incidence of approximately (1/5000 to 1/20000). Its link with autism spectrum disorders remains unknown although both are serious neurodevelopmental diseases. As part of the 2011-2013 Interregional hospital Clinical Research program, University Department of Child and Adolescent Psychiatry Pediatric Hospitals of CHU de Nice Lenval identified patients with a complex phenotype characterized by an early schizophrenia associated with autism spectrum disorders and developmental disabilities in mild to moderate. This phenotype could be a new syndrome. The goal of our project is to define the genetic causes of this phenotype. The technique of high throughput sequencing will be used to obtain the sequence of exomes of these patients and their families. This study will therefore be important to give an accurate diagnosis for patients and their families. Moreover, we believe that this project will identify new genes involved allowing a better understanding of the pathophysiology. Recent studies show the involvement of mutations in several genes (eg NRXN1 and UPF3B) in these different clinical phenotypes. However, the genetic basis of the childhood and early onset schizophrenia are much less well known than those of autism spectrum disorder
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable schizophrenia
Started May 2014
Longer than P75 for not_applicable schizophrenia
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 18, 2014
CompletedFirst Submitted
Initial submission to the registry
July 29, 2015
CompletedFirst Posted
Study publicly available on registry
October 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2023
CompletedSeptember 29, 2023
September 1, 2023
9 years
July 29, 2015
September 28, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
characterization of the genetic abnormalities associated to Early Onset Schizophrenia phenotypes by performing standard karyotype
A standard karyotype at a resolution of 300 to 400 bands per haploid lot. It can diagnose numerical anomalies and certain structural abnormalities such as reciprocal translocations, inversions, deletions. A standard karyotype at a resolution of 300 to 400 bands per haploid lot is established initially. It can diagnose numerical anomalies and certain structural abnormalities such as reciprocal translocations, inversions, deletions Big. The pathological nature of these mutations will be stutied on the gene function and reaches its pattern of expression.
inclusion visit
characterization of the genetic abnormalities associated to Early Onset Schizophrenia phenotypes by performing search CGG
A search of the CGG expansion hypermethylated in the 5 'UTR of the FMR1 gene mutation that causes Fragile X syndrome.
inclusion visit
characterization of the genetic abnormalities associated to Early Onset Schizophrenia phenotypes by performing whole exome sequencing
Whole Exome Sequencing on trio (mother, father and child); This technology has demonstrated its power in recent years to determine the genetic causes of many rare diseases (Ropers, HH., 2012).
inclusion visit
Secondary Outcomes (6)
Intensity of positive symptoms of schizophrenia
inclusion visit
Co-morbid psychiatric diagnosis
inclusion visit
Evaluation of executive and attentional by the verbal fluency test
inclusion visit
Clinical evaluation of autistic symptoms
inclusion visit
Neurocognitive profile
inclusion visit
- +1 more secondary outcomes
Study Arms (1)
genetic and phenotypic profile
EXPERIMENTALblood sample, clinical and neurocognitive assessment
Interventions
Genetic and phenotypic profile, clinical and neurocognitive assessment for child with Schizophrenia and autism, their parents and brotherhood
Eligibility Criteria
You may qualify if:
- Of the child:
- ≥ 7 years, \<18 (below 7 years the diagnosis of schizophrenia is not possible)
- Schizophrenia Diagnosis done using the diagnostic tool Kiddie sads
- Autism Diagnosis done using the diagnostic scale Autism Diagnostic interview (ADI-R)
- Intelligence quotient (IQ) ≥ 50 at Wechsler Intelligence Scale for Children (WISC) IV abridged version
- Clinical examination
- Affiliation to social security
- Obtaining the authorization of the holders of parental authority
- Brothers and sisters:
- Minor or Major
- Similarly biological parents
- Clinical examination
- Affiliation to social security
- Obtaining the authorization of the holders of parental authority for minors or informed consent for major
- Parents:
- +4 more criteria
You may not qualify if:
- Of the child:
- Children refusing to participate
- Children without verbal language
- Brothers and sisters:
- Children refusing to participate
- Adults protected by law
- Parents:
- Refusing to participate
- Adults are protected by law
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fondation Lenvallead
Study Sites (1)
Fondation Lenval
Nice, 06200, France
Related Publications (1)
Fernandez A, Dor E, Maurin T, Laure G, Menard ML, Drozd M, Poinso F, Bardoni B, Askenazy F, Thummler S. Exploration and characterisation of the phenotypic and genetic profiles of patients with early onset schizophrenia associated with autism spectrum disorder and their first-degree relatives: a French multicentre case series study protocol (GenAuDiss). BMJ Open. 2018 Jul 5;8(7):e023330. doi: 10.1136/bmjopen-2018-023330.
PMID: 29980548DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emmanuelle DOR, MD
Fondation Lenval
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 29, 2015
First Posted
October 1, 2015
Study Start
May 18, 2014
Primary Completion
May 30, 2023
Study Completion
May 30, 2023
Last Updated
September 29, 2023
Record last verified: 2023-09